Alemtuzumab (Campath) in relapsed or refractory CLL or PLL.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • McCune, SL; Gockerman, JP; Moore, JO; deCastro, CM; Bass, AJ; Chao, NJ; Long, GD; Vredenburgh, JJ; Gasparetto, C; Adams, DB; Payne, NP; Rizzieri, DA

Published Date

  • November 16, 2001

Published In

Volume / Issue

  • 98 / 11

Start / End Page

  • 290B - 291B

Published By

Pages

  • 2

International Standard Serial Number (ISSN)

  • 0006-4971

Language

  • English